“…Abbreviations: 3T, 3-Tesla; ADC, apparent diffusion coefficient; ANLS, astrocyte neuron lactate shuttle; AUC, area under the curve; BGT, basal ganglia, thalamus; CC3, cleaved caspase 3; Cho, choline; Cr, creatine; DGM, Deep gray matter; DWI, diffusion-weighted imaging; FA, fractional anisotropy; HI, hypoxia-ischemia; HT, therapeutic hypothermia; Iba1, ionized calcium-binding adapter molecule 1; Lac/NAA, lactate/N-acetylaspartate; Lac, lactate; LPS, lipopolysaccharide; MD, mean diffusivity; MRS, magnetic resonance spectroscopy; NAA, N-acetylaspartate; NAAG, N-acetylaspartylglutamate; NAD, nicotinamide adenine dinucleotide; NE, neonatal encephalopathy; RCT, randomized controlled trial; ROI, region of Over the last two decades, we have used BGT and white matter (WM) Lac/NAA as one of our primary outcome markers in neuroprotection studies of adjunct therapies with HT in our piglet model (11)(12)(13)(14)(15). The piglet model allows for regional assessment of brain immunohistochemistry at 48 h with analyses including quantification of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells, assessment of neuroinflammation [ionized calcium-binding adapter molecule 1 (Iba1) ramification index], and quantification of cleaved caspase 3 (CC3), a marker of caspase-dependent apoptosis.…”